vs

Side-by-side financial comparison of HYDROFARM HOLDINGS GROUP, INC. (HYFM) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

HYDROFARM HOLDINGS GROUP, INC. is the larger business by last-quarter revenue ($25.1M vs $13.2M, roughly 1.9× TriSalus Life Sciences, Inc.). TriSalus Life Sciences, Inc. runs the higher net margin — -73.9% vs -963.9%, a 890.0% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs -32.7%). TriSalus Life Sciences, Inc. produced more free cash flow last quarter ($-2.5M vs $-4.3M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs -31.9%).

Hydrofarm Inc. (HYFM) is an American company specializing in the distribution and manufacture of controlled environment agriculture equipment and supplies.

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

HYFM vs TLSI — Head-to-Head

Bigger by revenue
HYFM
HYFM
1.9× larger
HYFM
$25.1M
$13.2M
TLSI
Growing faster (revenue YoY)
TLSI
TLSI
+92.5% gap
TLSI
59.8%
-32.7%
HYFM
Higher net margin
TLSI
TLSI
890.0% more per $
TLSI
-73.9%
-963.9%
HYFM
More free cash flow
TLSI
TLSI
$1.8M more FCF
TLSI
$-2.5M
$-4.3M
HYFM
Faster 2-yr revenue CAGR
TLSI
TLSI
Annualised
TLSI
43.0%
-31.9%
HYFM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HYFM
HYFM
TLSI
TLSI
Revenue
$25.1M
$13.2M
Net Profit
$-242.2M
$-9.8M
Gross Margin
8.5%
86.7%
Operating Margin
-953.8%
-24.8%
Net Margin
-963.9%
-73.9%
Revenue YoY
-32.7%
59.8%
Net Profit YoY
-1282.7%
3.5%
EPS (diluted)
$-52.09
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HYFM
HYFM
TLSI
TLSI
Q4 25
$25.1M
$13.2M
Q3 25
$29.4M
$11.6M
Q2 25
$39.2M
$11.2M
Q1 25
$40.5M
$9.2M
Q4 24
$37.3M
$8.3M
Q3 24
$44.0M
$7.3M
Q2 24
$54.8M
$7.4M
Q1 24
$54.2M
$6.5M
Net Profit
HYFM
HYFM
TLSI
TLSI
Q4 25
$-242.2M
$-9.8M
Q3 25
$-16.4M
$-10.8M
Q2 25
$-16.9M
$-8.3M
Q1 25
$-14.4M
$-10.4M
Q4 24
$-17.5M
$-10.1M
Q3 24
$-13.1M
$-2.4M
Q2 24
$-23.4M
$-4.3M
Q1 24
$-12.6M
$-13.2M
Gross Margin
HYFM
HYFM
TLSI
TLSI
Q4 25
8.5%
86.7%
Q3 25
11.6%
83.5%
Q2 25
7.1%
83.9%
Q1 25
17.0%
83.7%
Q4 24
4.9%
85.3%
Q3 24
19.4%
86.3%
Q2 24
19.8%
87.6%
Q1 24
20.2%
85.0%
Operating Margin
HYFM
HYFM
TLSI
TLSI
Q4 25
-953.8%
-24.8%
Q3 25
-44.1%
-77.9%
Q2 25
-34.0%
-65.4%
Q1 25
-27.1%
-79.9%
Q4 24
-40.5%
-91.8%
Q3 24
-20.5%
-118.9%
Q2 24
-35.3%
-111.0%
Q1 24
-16.1%
-180.8%
Net Margin
HYFM
HYFM
TLSI
TLSI
Q4 25
-963.9%
-73.9%
Q3 25
-55.8%
-93.5%
Q2 25
-43.0%
-73.9%
Q1 25
-35.5%
-113.2%
Q4 24
-46.9%
-122.4%
Q3 24
-29.9%
-32.6%
Q2 24
-42.8%
-58.8%
Q1 24
-23.3%
-204.5%
EPS (diluted)
HYFM
HYFM
TLSI
TLSI
Q4 25
$-52.09
$-0.22
Q3 25
$-3.51
$-0.96
Q2 25
$-3.63
$-0.27
Q1 25
$-3.12
$-0.39
Q4 24
$-3.80
$-0.38
Q3 24
$-2.86
$-0.12
Q2 24
$-5.10
$-0.21
Q1 24
$-2.75
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HYFM
HYFM
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$6.3M
$20.4M
Total DebtLower is stronger
$50.0K
Stockholders' EquityBook value
$-63.3M
$-33.9M
Total Assets
$123.8M
$35.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HYFM
HYFM
TLSI
TLSI
Q4 25
$6.3M
$20.4M
Q3 25
$10.7M
$22.7M
Q2 25
$11.0M
$26.5M
Q1 25
$13.7M
$13.0M
Q4 24
$26.1M
$8.5M
Q3 24
$24.4M
$11.3M
Q2 24
$30.3M
$16.5M
Q1 24
$24.2M
$4.0M
Total Debt
HYFM
HYFM
TLSI
TLSI
Q4 25
$50.0K
Q3 25
$111.7M
Q2 25
$111.6M
Q1 25
$110.0M
Q4 24
$114.7M
Q3 24
$114.8M
Q2 24
$114.9M
Q1 24
$115.4M
Stockholders' Equity
HYFM
HYFM
TLSI
TLSI
Q4 25
$-63.3M
$-33.9M
Q3 25
$178.3M
$-26.7M
Q2 25
$195.0M
$-19.4M
Q1 25
$209.9M
$-34.4M
Q4 24
$223.7M
$-25.9M
Q3 24
$243.0M
$-20.4M
Q2 24
$255.0M
$-25.3M
Q1 24
$278.0M
$-36.0M
Total Assets
HYFM
HYFM
TLSI
TLSI
Q4 25
$123.8M
$35.3M
Q3 25
$369.7M
$36.5M
Q2 25
$389.9M
$41.3M
Q1 25
$410.6M
$28.6M
Q4 24
$426.1M
$24.0M
Q3 24
$445.9M
$27.5M
Q2 24
$463.4M
$32.4M
Q1 24
$494.0M
$17.9M
Debt / Equity
HYFM
HYFM
TLSI
TLSI
Q4 25
Q3 25
0.63×
Q2 25
0.57×
Q1 25
0.52×
Q4 24
0.51×
Q3 24
0.47×
Q2 24
0.45×
Q1 24
0.42×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HYFM
HYFM
TLSI
TLSI
Operating Cash FlowLast quarter
$-4.0M
$-2.5M
Free Cash FlowOCF − Capex
$-4.3M
$-2.5M
FCF MarginFCF / Revenue
-17.1%
-19.1%
Capex IntensityCapex / Revenue
1.3%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HYFM
HYFM
TLSI
TLSI
Q4 25
$-4.0M
$-2.5M
Q3 25
$-37.0K
$-3.7M
Q2 25
$1.7M
$-7.3M
Q1 25
$-11.8M
$-4.5M
Q4 24
$2.7M
$-5.7M
Q3 24
$-4.5M
$-10.8M
Q2 24
$3.8M
$-13.4M
Q1 24
$-2.3M
$-10.9M
Free Cash Flow
HYFM
HYFM
TLSI
TLSI
Q4 25
$-4.3M
$-2.5M
Q3 25
$-207.0K
$-3.9M
Q2 25
$1.4M
$-7.4M
Q1 25
$-12.0M
$-5.3M
Q4 24
$2.4M
$-5.8M
Q3 24
$-5.3M
$-11.0M
Q2 24
$3.4M
$-13.5M
Q1 24
$-3.7M
$-10.9M
FCF Margin
HYFM
HYFM
TLSI
TLSI
Q4 25
-17.1%
-19.1%
Q3 25
-0.7%
-33.9%
Q2 25
3.7%
-66.1%
Q1 25
-29.6%
-57.3%
Q4 24
6.4%
-69.7%
Q3 24
-12.0%
-149.9%
Q2 24
6.2%
-183.1%
Q1 24
-6.9%
-169.3%
Capex Intensity
HYFM
HYFM
TLSI
TLSI
Q4 25
1.3%
0.3%
Q3 25
0.6%
1.9%
Q2 25
0.7%
0.8%
Q1 25
0.6%
8.2%
Q4 24
0.7%
0.6%
Q3 24
1.8%
2.3%
Q2 24
0.7%
0.8%
Q1 24
2.7%
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons